ANNORA PHARMA FDA Approval ANDA 214831

ANDA 214831

ANNORA PHARMA

FDA Drug Application

Application #214831

Application Sponsors

ANDA 214831ANNORA PHARMA

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003
None (Tentative Approval)004
None (Tentative Approval)005

Application Products

002TABLET; ORAL25mg0BRIVARACETAMBRIVARACETAM
003TABLET; ORAL50mg0BRIVARACETAMBRIVARACETAM
004TABLET; ORAL75mg0BRIVARACETAMBRIVARACETAM
005TABLET; ORAL100mg0BRIVARACETAMBRIVARACETAM

FDA Submissions

UNKNOWN; ORIG1TA2022-06-01STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214831
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.